Breaking News, Collaborations & Alliances

Moderna and ROVI Ink Fill-Finish Deal

Collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate.

By: Contract Pharma

Contract Pharma Staff

Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Laboratorios Farmacéuticos Rovi, S.A., a pan-European pharmaceutical company specializing and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties, have formed a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA vaccine candidate against COVID-19 (mRNA-1273) at ROVI’s facility in Mad...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters